<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biomed Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Biomed Rep</journal-id>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29403643</article-id>
<article-id pub-id-type="pmc">5780767</article-id>
<article-id pub-id-type="doi">10.3892/br.2017.1019</article-id>
<article-id pub-id-type="publisher-id">BR-0-0-1019</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Down syndrome and microRNAs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Brás</surname>
<given-names>Aldina</given-names>
</name>
<xref ref-type="aff" rid="af1-br-0-0-1019"></xref>
<xref ref-type="corresp" rid="c1-br-0-0-1019"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodrigues</surname>
<given-names>António S.</given-names>
</name>
<xref ref-type="aff" rid="af1-br-0-0-1019"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gomes</surname>
<given-names>Bruno</given-names>
</name>
<xref ref-type="aff" rid="af1-br-0-0-1019"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rueff</surname>
<given-names>José</given-names>
</name>
<xref ref-type="aff" rid="af1-br-0-0-1019"></xref>
</contrib>
</contrib-group>
<aff id="af1-br-0-0-1019">Centre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, NOVA Medical School, Faculty of Medical Sciences, NOVA University of Lisbon, 1169-056 Lisbon, Portugal</aff>
<author-notes>
<corresp id="c1-br-0-0-1019"><italic>Correspondence to</italic>: Professor Aldina Brás, Centre for Toxicogenomics and Human Health (ToxOmics), Genetics, Oncology and Human Toxicology, NOVA Medical School, Faculty of Medical Sciences, NOVA University of Lisbon, 130 Campo dos Mártires da Pátria, 1169-056 Lisbon, Portugal, E-mail: <email>aldina.bras@nms.unl.pt</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>11</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>8</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>16</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018, Spandidos Publications</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>In recent years numerous studies have indicated the importance of microRNAs (miRNA/miRs) in human pathology. Down syndrome (DS) is the most prevalent survivable chromosomal disorder and is attributed to trisomy 21 and the subsequent alteration of the dosage of genes located on this chromosome. A number of miRNAs are overexpressed in down syndrome, including miR-155, miR-802, miR- 125b-2, let-7c and miR-99a. This overexpression may contribute to the neuropathology, congenital heart defects, leukemia and low rate of solid tumor development observed in patients with DS. MiRNAs located on other chromosomes and with associated target genes on or off chromosome 21 may also be involved in the DS phenotype. In the present review, an overview of miRNAs and the haploinsufficiency and protein translation of specific miRNA targets in DS are discussed. This aimed to aid understanding of the pathogenesis of DS, and may contribute to the development of novel strategies for the prevention and treatment of the pathologies of DS.</p>
</abstract>
<kwd-group>
<kwd>Down syndrome</kwd>
<kwd>microRNAs</kwd>
<kwd>trisomy 21</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>